8/6/2026
Mississauga man charged after Cambridge man's death
Incident occurred during a 'healing experience' involving ibogaine.
Topic archive
ibogaine
50 stories
8/6/2026
Barrow Institute gets $5M for ibogaine brain injury trial
The trial will explore ibogaine's potential in treating chronic TBI symptoms.
8/6/2026
Barrow begins ibogaine trial for brain injury recovery
Arizona-funded study explores ibogaine's potential for neurological disorders.
8/6/2026
Ibogaine ceremony death leads to charges in Canada
Mississauga man charged after fatal ibogaine ceremony in Waterloo Region.
8/6/2026
Ibogaine use linked to sudden death in Canada
Police arrest man in Mississauga following ibogaine-related death investigation.
8/5/2026
Ibogaine research review highlights safety concerns
Thirty years of ibogaine studies reveal potential but highlight risks.
8/5/2026
Ibogaine death in Cambridge prompts police warning
Police charge Mississauga man after ibogaine-related death, highlighting risks.
8/5/2026
Ibogaine healing experience linked to sudden death in Ontario
Police in Cambridge, Ontario, investigate death after ibogaine use.
8/5/2026
Mississauga man charged after Cambridge man's ibogaine-related death
The incident raises concerns about ibogaine's safety in unregulated settings.
8/5/2026
Barrow Neurological Institute receives $5M for ibogaine study
Grant supports research into ibogaine's effects on neurological disorders.
8/5/2026
Ibogaine's impact on PTSD: A new hope for veterans
Jonathan Dickinson discusses ibogaine's potential in treating PTSD and brain injuries.
8/4/2026
Ibogaine clinic adopts Jungian approach for trauma
Minimalist therapy model emphasizes patient-led recovery
7/31/2026
Ibogaine research gains momentum in Mississippi
Mississippi explores ibogaine trials for addiction treatment, reflecting a shift towards health-centered drug policies.
7/31/2026
Congressman Luttrell champions ibogaine for PTSD treatment
Luttrell's IBOGAINE Act aims to solidify psychedelic therapy access for veterans.
7/30/2026
Scottsdale Research Institute submits new ibogaine IND
The institute seeks approval to study ibogaine's potential in treating addiction.
7/29/2026
Ibogaine research faces representation challenges
Psychedelic trials often exclude marginalized groups, raising questions about equity and efficacy.
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas receives federal funding, advancing research into opioid treatment.
7/29/2026
Scottsdale Research Institute submits IND for ibogaine
Ibogaine HCl aims to treat PTSD, TBI, and opioid use disorder.
7/29/2026
Universal Ibogaine Inc. financials overview
A look at the financials of Universal Ibogaine Inc.
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas gains federal backing, marking a significant research development.
7/29/2026
Texas begins state-led ibogaine research with federal support
The new program aims to explore ibogaine's potential in treating opioid addiction.
7/29/2026
Universal Ibogaine Inc market sentiment update
Market sentiment for Universal Ibogaine Inc remains under review.
7/28/2026
Ibogaine inquiries on YouTube spark interest
YouTube video explores ibogaine's potential in treating disorders.
7/27/2026
Ibogaine treatment provision included in defense bill
New NDAA provision aims to expand ibogaine access for veterans.
7/24/2026
Ibogaine aids ketamine abstinence, case report suggests
Case report highlights ibogaine's potential in treating severe ketamine use disorder.
7/24/2026
Heidi Overton's role in Trump's ibogaine policy
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.
7/24/2026
Joe Rogan's ibogaine advocacy sparks White House tension
Rogan's push for ibogaine approval led to conflict with a key Trump aide.
7/24/2026
Trump administration fast-tracks ibogaine research
Psychoactive drug ibogaine gains attention for addiction treatment potential.
7/24/2026
Trump administration fast-tracks ibogaine research
Ibogaine research gains momentum under Trump administration's expedited process.
7/24/2026
Experience Ibogaine supports 3,000 patients in recovery
The Tijuana-based center marks a milestone in ibogaine treatment for substance use disorder.
7/24/2026
Ibogaine may gain U.S. access under Trump administration
The Trump administration considers making ibogaine available for therapeutic use.
7/23/2026
Trump administration considers ibogaine for addiction treatment
Ibogaine, a psychedelic, eyed for opioid crisis intervention under Trump.
7/23/2026
Trump executive order boosts psychedelic therapy research
Order encourages psychedelic research, allocates $50M for state studies.
7/23/2026
McCaul supports NDAA amendment for veteran ibogaine access
The amendment aims to expand treatment options for PTSD and addiction.
7/23/2026
Ibogaine research and inquiries on YouTube
YouTube video explores ibogaine's potential in treating addiction.
7/23/2026
Ibogaine access expanded for veterans in FY27 NDAA
New provisions in the NDAA aim to enhance veteran care and strengthen global defense partnerships.
7/22/2026
McCaul advocates for ibogaine access for veterans
Proposed NDAA amendment aims to expand treatment options for PTSD and TBI.
7/21/2026
Ibogaine reduces PTSD symptoms by 88% in study
Stanford Veterans Study highlights ibogaine's potential for PTSD treatment.
7/17/2026
Ibogaine's long-term brain effects explored
Psychedelics like ibogaine may offer lasting brain changes.
7/16/2026
San Antonio mayor advocates for ibogaine trials
Mayor Gina Ortiz Jones pushes for psychedelic trials to aid veterans.
7/16/2026
Texas leaders advocate ibogaine research
Veterans report transformative effects from psychedelic treatment.
7/16/2026
Texas leaders advocate ibogaine research
Veterans report transformative effects from psychedelic therapy.
7/16/2026
Ibogaine: A psychoactive compound with potential
Ibogaine's role in treating substance use disorders remains controversial.
7/16/2026
Texas leaders advocate for ibogaine research
Veterans share recovery stories, highlighting ibogaine's potential.
7/15/2026
Royal Ontario Museum hosts psychedelics exhibit
Exhibit explores the evolving role of psychedelics in culture and medicine.
7/15/2026
HHS and VA collaborate to advance psychedelic therapy
New agreement includes ibogaine research for opioid use disorder.
7/15/2026
US backs psychedelic therapy research for veterans
Federal support for ibogaine and other psychedelics aims to aid veterans with PTSD.
7/8/2026
Congress Introduces IBOGAINE Act to Enhance Psychedelics Legislation
Bipartisan Effort Aims to Reschedule Ibogaine and Expand Therapy Access
7/8/2026
Ibogaine's Legal Status and Clinical Trials
An Overview of Ibogaine's Journey in the U.S.
7/8/2026
Ibogaine trials advance amid complex legal status
Ibogaine remains illegal in the U.S., yet clinical trials are underway.